Investor's Business Daily on MSN
This biotech's LSD-based drug just treated depression. Now the stock is sky-high.
Definium Therapeutics skyrocketed Monday after its psychedelics-based depression treatment scored a "best-case" win in ...
Scientists have long known that psychedelics like LSD can help the brain grow new connections. These drugs promote something called neuroplasticity, which helps the brain heal from mental illness. But ...
People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, ...
The biotech’s LSD recipe, known as DT120 ODT, scored wins on all primary and key secondary endpoints of the 149-patient Emerge trial, Definium announced Monday, June 22, marking a reduction in ...
Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing ...
The latest LSD-based drug was used in a clinical trial to support patients with major depression in an initial step in ...
Project MKUltra remains one of the CIA's most controversial covert operations. Launched in the early Cold War, the secret program explored whether drugs such as LSD and other techniques could be used ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results